Activest Wealth Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Activest Wealth Management’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$48.6K	Hold	3,000	–	–	0.01%	279
2026 Q2	$50.9K	Hold	3,000	–	–	0.01%	276
2026 Q1	$44.5K	Hold	3,000	–	–	0.01%	359
2025 Q4	$47.8K	Hold	3,000	–	–	0.01%	326
2025 Q3	$33.2K	Hold	3,000	–	–	0.01%	307
2025 Q2	$25.4K	Hold	3,000	–	–	0.01%	285
2025 Q1	$24.1K	Hold	3,000	–	–	0.01%	269
2024 Q4	$26.9K	Hold	3,000	–	–	0.01%	223
2024 Q3	$22K	Hold	3,000	–	–	0.01%	246
2024 Q2	$17.1K	Buy	+3,000	New	+$15.8K	0.01%	248

Other funds holding AUPH

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Activest Wealth Management's AUPH Position: Q3 2026 in Review

Activest Wealth Management held its Aurinia Pharmaceuticals (AUPH) position steady in Q3 2026 at 3,000 shares worth $48.6K. The position accounts for 0.01% of the portfolio, ranked #279.

Activest Wealth Management first reported a position in AUPH in Q2 2024 and has held it in 10 quarters since. The position peaked at $50.9K in Q2 2026. 210 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

Activest Wealth Management held 3,000 shares of Aurinia Pharmaceuticals worth $48.6K as of Q3 2026.
Activest Wealth Management left its Aurinia Pharmaceuticals share count unchanged in Q3 2026.
Aurinia Pharmaceuticals made up 0.01% of Activest Wealth Management's portfolio in Q3 2026, its #279 holding.
Activest Wealth Management first reported a position in Aurinia Pharmaceuticals in Q2 2024 and has held it in 10 quarters since.
Activest Wealth Management's Aurinia Pharmaceuticals position peaked at $50.9K in Q2 2026.
210 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.